First-line treatment with abciximab does not reduce...

First-line treatment with abciximab does not reduce mortality or myocardial infarction in people with acute coronary syndromes not undergoing early revascularization

Christopher P Cannon
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
5
Year:
2001
Language:
english
DOI:
10.1054/ebcm.2001.0418
File:
PDF, 238 KB
english, 2001
Conversion to is in progress
Conversion to is failed